Blood Test News and Research

RSS

New blood test for early stage ovarian cancer

Australian researchers say they have developed an accurate blood test to detect the first stages of ovarian cancer.

3 Mar 2008

Customized treatments for sepsis lower treatment time and reduce length of ICU stays

Using a blood test and a decision algorithm, rather than standard hospital protocols, to determine the appropriate length of antibiotic therapy in patients with severe sepsis or septic shock can reduce duration of treatments, shorten ICU stays, and lower hospital costs - all without adverse effects on patients, according to new research.

1 Mar 2008

New blood biomarker accurately predicts spread of prostate cancer to regional lymph nodes

Researchers report finding a new blood biomarker that enables close to 98 percent accuracy in predicting the spread of prostate cancer to regional lymph nodes.

28 Feb 2008

GP's databases could identify tens of thousands with undiagnosed diabetes in UK

Researchers who examined blood test records in a survey of over 3.6 million patient records held by UK GP surgeries have found thousands of cases of probable undiagnosed diabetes.

26 Feb 2008

Mosquito bourne diseases cause concern in three areas of Australia

Australian Health officials have issued public health warnings about mosquito bourne diseases in three areas.

25 Feb 2008

Multiple approaches to type 1 diabetes

Type 1 diabetes, formerly called insulin-dependent diabetes, juvenile diabetes or childhood-onset diabetes, affects 1 to 2 million people in the U.S. and millions more worldwide.

21 Feb 2008

New blood test six times more effective for tuberculosis control

In a landmark study electronically published today in the American Journal of Respiratory and Critical Care Medicine, a blood test for detecting TB infection, QuantiFERON(R)-TB Gold (QFT), has been shown to be six times more accurate than the conventional tuberculin skin test (TST) at predicting which tuberculosis (TB)-exposed individuals will go on to develop TB disease.

18 Feb 2008

PSA testing predicts advanced prostate cancer

A single prostate specific antigen (PSA) test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan-Kettering Cancer Center in New York and Lund University in Sweden.

18 Feb 2008

Post-traumatic stress disorder leads to long-term health problems

Geisinger research finds that veterans suffering from posttraumatic stress disorder (PTSD) are as likely to have long-term health problems as people with chronic disease risk factors such as an elevated white blood cell counts and biological signs and symptoms.

14 Feb 2008

Blood test detects early stage ovarian cancer with 99 percent accuracy

Researchers at Yale School of Medicine have developed a blood test with enough sensitivity and specificity to detect early stage ovarian cancer with 99 percent accuracy.

13 Feb 2008

Health care providers play key role in likelihood their patients are screened for colorectal cancer

The findings suggest that interventions targeting both the provider and the patient are needed to boost colorectal cancer screening rates, and in particular must take into account patient barriers such as concerns about payment and worries that cancer will be discovered.

12 Feb 2008

Revelation of new genes linked to prostate cancer could single out high risk men

The discovery by researchers of at least ten new genes associated with prostate cancer could in future be used to accurately identify high-risk men.

11 Feb 2008

Seniors more likely to deny smoking when asked

More elderly adults are lighting up cigarettes and not reporting their nicotine habits to doctors and others, according to findings from one of the first studies to examine the accuracy of self-reported smoking habits by age, race and gender of adults 18 years and older by researchers at the Case Western Reserve University School of Dental Medicine and other university collaborators.

8 Feb 2008

Australian gene test opens door to personalised care

Australian researchers have led a study published in the New England Journal of Medicine that shows a simple blood test can allow doctors to predict which HIV patients will have a side effect, known as a hypersensitivity reaction, to a particular medication before it is prescribed.

6 Feb 2008

Experimental biomarker test beats PSA in detecting prostate cancer

An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.

5 Feb 2008

Stanford study finds transplant patient thrives 2 years after stopping immunosuppressive drugs

Luck smiled on Larry Kowalski when his brother agreed to donate a kidney Kowalski needed to live.

24 Jan 2008

Boston IVF to offer test of women's biological clock in the northeast

Boston IVF has announced it will be the first IVF center in the northeast to offer Repromedix's Plan Ahead test, an innovative blood test that provides an assessment of a woman's egg supply by combining multiple factors including the measurement of ovary-related hormones AMH, Inhibin B, and FSH.

22 Jan 2008

Previously unknown Merkel cell polyomavirus linked to deadly skin cancer

A new strategy to hunt for human viruses described in this week's issue of the journal Science by the husband-and-wife team who found the cause of Kaposi's sarcoma has revealed a previously unknown virus strongly associated with another rare but deadly skin cancer called Merkel cell carcinoma.

18 Jan 2008

Discovery opens door to 'personalized' asthma therapy

In the last few years, "personalized medicine" using genetic or other molecular biology-based diagnostic tests to customize treatment for a particular patient has emerged as a powerful new tool for health care.

18 Jan 2008

Takeda submits NDA for Alogliptin (SYR-322) in the U.S.

Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.

7 Jan 2008